12:00 AM
 | 
Feb 27, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Genecept Assay: Pilot trial started

Genomind began a blinded U.S. trial to use its Genecept Assay to evaluate assay-guided treatment in patients with treatment-resistant MDD.

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >